MarketPeel
Insider Trading Intelligence
Pricing
…
Chief R&D Commercial Officer
Khan Najat
Mon, Feb 3, 2025
Feb 3
bought
$0.00
of
RXRX
8,049
shares @ $0.00
Increased holdings by
+1.10%
18th largest trade (out of 19)
Cluster Buy
Trade made by an officer
Part of a cluster of 9 transactions by 3 insiders
Unscheduled trade
RXRX
RECURSION PHARMACEUTICALS, INC.
Healthcare
Biotechnology
1D
0.00%
1W
+7.95%
1M
0.00%
3M
—
6M
—
1Y
—
Recent insider activity at RXRX
Jun 18
Bumpus Namandje
Sold
$12.60k
Jun 5
Khan Najat
Sold
$84.46k
Jun 5
Gibson Christopher
Sold
$144.80k
Jun 3
Bumpus Namandje
Sold
$15.53k
Jun 2
Borgeson Blake
Sold
$110.40k
May 22
Gibson Christopher
Sold
$123.20k
May 7
Gibson Christopher
Sold
$134.80k
May 5
Borgeson Blake
Sold
$105.60k
Full RXRX profile →
Khan Najat’s trading history →
FREE · DAILY · 6 AM ET
The morning brief, before the bell.
One short email. Insider buys, congressional trades, and plain-English analysis.
Subscribe
Feedback